Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...
Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. As of January 29, 2025, the average one-year price ...
Wells Fargo initiated coverage of Dentsply Sirona (XRAY) with an Equal Weight rating and $20 price target The firm does not sees a “clean setup” into 2025 for Dentsply. It is hard to make a ...
12d
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...
Company Information Key Financials (last Fiscal Year) Profit Ratios Earnings Per Share (last Fiscal Year) Total Return © 2025 Fortune Media IP Limited. All Rights ...
DENTSPLY SIRONA (XRAY) has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect is a leading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback